Transcranial Direct Current Stimulation (tDCS) for Treatment of Negative Syndrome in Patients With Schizophrenia
NCT ID: NCT01378078
Last Updated: 2013-07-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2011-06-30
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of tDCS on Schizophrenia With Negative Symptoms
NCT03729791
Transcranial Direct Current Stimulation (tDCS) as a Treatment for Cognitive Deficits in Schizophrenic
NCT02748083
HD-tDCS for Hallucinations
NCT06208176
Disorder-tailored Transcranial Direct Current Stimulation (tDCS) of the Prefrontal Cortex
NCT02715128
Neuromodulation in Depressed and Schizophrenic Patients - Changing MEP (Muscle Evoked Potentials) by tDCS (Transcranial Direct Current Stimulation)
NCT01150734
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
sham
patients receive sham tDCS stimulation
eldith DC-stimulator (neuroconn, Ilmenau, Germany)
daily tDCS treatment over left DLPFC, 20 min, 2 mA
active
active transcranial direct current stimulation
eldith DC-stimulator (Neuroconn, Ilmenau, Germany)
same as sham stimulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
eldith DC-stimulator (neuroconn, Ilmenau, Germany)
daily tDCS treatment over left DLPFC, 20 min, 2 mA
eldith DC-stimulator (Neuroconn, Ilmenau, Germany)
same as sham stimulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ludwig-Maximilians - University of Munich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daniel Keeser
Ph.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ulrich Palm, MD
Role: PRINCIPAL_INVESTIGATOR
Ludwig Maximilian University Munich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinik fuer Psychiatrie
Munich, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
04/2011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.